Skip to Content



Definition: A monoclonal antibody directed against the HER2 receptor used as a targeted agent against malignancies overexpressing the HER2 protein on their cell surfaces.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.